Found 566 matching trials
Neprilysin Inhibition to Reduce Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction
PHASE4Cardiac magnetic resonance imaging (MRI) measures of myocardial interstitia...
Location
Multiple Locations
Valsartan Optimal Therapy Against Elevated Home Blood Pressure Research(VOYAGER)Study
PHASE4The purpose of this study is to compare improvement percentage of urinary a...
The Impact of Dose of Angiotensin-receptor Blocker Valsartan and Genetic Polymorphism on the Post-MI Ventricular Remodeling
PHASE4Angiotensin-converting enzyme inhibitors and angiotensin-receptor blocker v...
Location
Department of Internal Medicine,Dong-A University College of Medicine
Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin
PHASE3This study will assess and compare the efficacy and safety of valsartan and...
Location
Novartis Pharmaceuticals
Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.
PHASE4The purpose of this study is assess if treatment with valsartan and a diure...
Location
Novartis Pharmaceuticals
Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension
PHASE3The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial teste...
Location
Multiple Locations
Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3
PHASE3The purpose of the study is to see how two classes of blood pressure medica...
Location
Vanderbilt University Medical Center
Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy
PHASE4TO ASSESS THE EFFICACY OF THE RENIN ANGIOTENSIN SYSTEM PLUS STEROIDS TO DEC...
Location
Hospital Britanico de Buenos Aires
Study of the Efficacy and Safety of LCZ696 Alone and in Combination With Amlodipine in Patients With Hypertension
PHASE3To evaluate the blood pressure lowering effect and safety of LCZ696 when gi...
Location
Multiple Locations
A Study of Valsartan Administered Once Daily Versus Twice Daily, in Patients With Stable, Chronic Heart Failure
PHASE2This study will evaluate the tolerability and safety of valsartan in patien...
Location
Novartis Pharmaceuticals